Hungarian Investment Promotion Agency

Danish-based Xellia Pharmaceuticals is investing €70.85 million in Szigetszentmiklós, further strengthening Hungary's role in the European healthcare and antibiotic supply chain. The development aims to create a modern, automated pharmaceutical manufacturing pla...

2026. 03. 06.

Hungarian-owned Biolab Zrt. is strengthening Pest County through a capacity expansion investment.

2026. 02. 25.

French-owned Hungarian pharmaceutical company Egis Gyógyszergyár Zrt. is set to implement another large-scale investment to boost efficiency and capacity at its base in Körmend.

2025. 07. 28.

Swiss-owned Novartis expands its Hungarian presence by adding a regional R&D center. Apart from its core research functions, the facility will play a crucial role in coordinating related activities in several countries.

2023. 05. 05.